Transplant International

Kidney.- Rat cytomegalovirus infection and chronic kidney allograft rejection.- Does delayed kidney graft function increase the risk of chronic rejection?.- Evaluation of the permissible mismatch concept.- The significant effect of HLA-DRB1 matching on acute rejection in kidney transplants.- Five-year results of renal transplantation in highly sensitized recipients.- Anticipation of highly sensitised renal patients' immunoadsorption requirements by prescreening using protein A minicolumns.- Weak expression of blood type B antigen in kidney tissue and successful B-incompatible kidney transplantation without special treatments.- Outcome of renal graft recipients with hepatitis C virus infection.- Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients.- Acute rejection relapses posttransplant: definition of risk group and evaluation of potent therapeutic regimens.- Steroid-resistance rejection in kidney-transplanted patients: is ATG treatment for three or ten days preferable?.- Randomized trial of misoprostol in patients with chronic renal transplant rejection.- Increased tenascin expression is an early feature of the development of transplant renal arteriopathy in humans.- Is kidney transplantation in sensitized recipients justified?.- Low-density lipoprotein oxidation is increased in kidney transplant recipients.- The anaphylatoxin C5a, new parameter in the diagnosis of renal allograft rejection.- A critical analysis of soluble interleukin-2 receptor levels in kidney allograft recipients.- Diagnostic value of urinary enzyme determination in renal transplantation.- Retroperitoneal placement of living related adult renal grafts in children less than 5 years of age - a feasible technique?.- Short-term outcome of kidney transplants from non-heart-beating donors after preservation by machine perfusion.- Transplantation of kidneys harvested from non-heart-beating donors: early and long-term results.- Effective surface cooling of the kidney during vascular anastomosis decreases the risk of delayed kidney function after transplantation.- Kidney transplantation to patients with congenital malformations of the distal urinary tract.- Liver.- Impact of enalapril on microvascular perfusion and leukocyte adherence in a model of rat liver transplantation assessed by in vivo microscopy.- Quantitative analysis of the microcirculation of xenogeneic haemoperfused rat livers by intravital microscopy.- Beneficial effects of prostaglandin E1on hemodynamic changes during liver transplantation in pigs.- Pharmacokinetics of intravenous adriamycin for anhepatic chemotherapy during liver transplantation.- Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival.- DNA flow cytometry in patients undergoing liver transplantation for hepatocellular carcinoma.- Clinical significance of recurrent primary biliary cirrhosis after liver transplantation.- Hepatic resuscitation after warm anoxia: one approach for increasing the donor pool for liver transplantation.- Cytokine pattern in patients with infections after liver transplantation.- Prediction of graft dysfunction by analysis of liver biopsies after cold storage.- Validation of endothelin (ET) immunoreactivity in human bile by HPLC. Comparison of biliary ET concentration in liver transplant recipients with values obtained during cholecystectomy.- First clinical realization of continuous monitoring of liver microcirculation after transplantation by thermodiffusion.- Two-year data from the European multicentre tacrolimus (FK 506) liver study.- Tumor recurrence after oLTX.- The importance of late infections for the long-term outcome after liver transplantation.- Living related liver transplantation in children with hypoxemia related to intrapulmonary shunting.- Growth and height in children after liver transplantation.- Indications for Tacrolimus anti-rejection therapy in liver allograft recipients.- Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.- Extension of the indication for living related liver transplantation from children to adults based on resolution of graft size mismatch in relation to tissue oxygenation and metabolic load: a case report.- Incidence and outcome of arterial complications after orthotopic liver transplantation.- Hepato-venous outflow complications following orthotopic liver transplantation with various techniques for hepato-venous reconstruction in adults and children.- Bile duct splintage in liver transplantation: is it necessary?.- Effect of pre-reperfusion portal venous blood flush on early liver transplant function.- How to estimate the size of the donor liver.- Is hepatitis C virus recurrence a risk factor for chronic liver allograft rej ection?.- Hepatitis C: indication for anti-viral therapy?.- Effectiveness of early a-interferon therapy for hepatitis C virus infection recurrence after liver transplantation.- Hepatitis C virus Genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients.- Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.- Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection.- Heart/Lung.- Arrhythmogenic mortality in heart-transplant candidates.- Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts.- Difference in cytokine production in acute and chronic rejection of rat lung allografts.- Pravastatin prevents the progression of accelerated coronary artery disease after heart transplantation in a rabbit model.- HLA-DR matching reduces rejection rate in heart transplantation.- Phenotypic analysis of lymphocytes infiltrating human cardiac allografts during acute rejection and the development of graft vascular disease.- Patterns in donor-specific mRNA and protein production of Thl and Th2 cytokines by graft-infiltrating lymphocytes and PBMC after heart transplantation.- Relationship between CMV and graft rejection after heart transplantation.- Evoked epimyocardial electrogram for rejection diagnosis after heart transplantation.- Valve reconstruction or replacement for long-term biopsy-induced tricuspid regurgitation following heart transplantation.- Pancreas.- Use of FK 506 in pancreas transplantation.- Liposoluble antioxidants are not consumed in the pancreas after reperfusion in human simultaneous pancreas-kidney transplantation.- Small Bowel.- circumvention of natural killer cell and T-cell mediated allogeneic target killing with tacrolimus (FK 506) in small bowel transplantation related graft-vs-host disease.- Colon vs small bowel rejection after total bowel transplantation in a pig model.- In vivo depletion of NKR-P1 positive cells in the recipient prior to small bowel transplantation enhances graft-versus-host disease (GvHD) in the rat.- Changes in blood lymphocytes populations in experimental bowel allograft rejection.- Microsurgical reconstruction of the lymphatic and nerve system in small bowel transplantation: the rat model, first results.- Lung.- Chronic rejection in lung allografts: immunohistological analysis of fibrogenesis.- Clinical experience with retrograde lung preservation.- Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation.- Immunosuppression.- Predicting patients' exposure to cyclosporin.- Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysis.- UK multicentre study to assess the safety and tolerability of Neoral in stable renal transplant patients.- Comparison of Sandimmun with a new cyclosporin derivative (IMM 125) in renal transplant patients with stable renal function.- Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin A.- Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the rat.- A short-term combination therapy with cyclosporine and rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats.- Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival.- Immunobiology.- Rat MHC class I peptidase are immunogenic.- Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aortic allografts.- Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathways.- Liver sinusoidal lymphocytes: their immune functions.- Determination of HLA-B7 T-cell epitopes.- HLA class I A and B typing in the clinical laboratory using DNA-based techniques.- Flow cytometric crossmatching in renal transplantation - outcome after five years.- Allograft tolerance by intrathymic donor splenocyte transfer: an age-dependent, species-specific phenomenon?.- Total lymphoid irradiation, without intrathymic injection of donor cells, induces indefinite acceptance of heart but not islet or skin allografts in rats.- Induction of specific inhibition of alloreativity in beagle dogs by intrathymic injection of donor splenocytes.- Xenotransplantation.- Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion - immunopathological findings.- Long-duration xenogeneic extracorporeal pig liver perfusion with human blood.- The function of transgenic human DAF-expression porcine livers during hemoperfusion with human blood.- Costs of drugs used after renal transplantation.- Ethical aspects of using "marginal" kidneys for transplant.- Organ Procurement.- Donor heart quality control. Analysis of echocardiographic (EC) findings and patient outcome.- Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria.- The impact of donor age on graft outcome after liver transplantation.- The anti-ischemic drugs defibrotide and oligotide analogously inhibit leukocyte-endothelial cell adhesion in vitro.- Reduction in nonparenchymal cell injury and vascular endothelial dysfunction after cold preservation of the liver by gaseous oxygen.- Influence of UW solution on in vitro platelet aggregability.- Why is liver preservation performed at 4 °C?.- Na-K/2C1 transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion.- Minimal amounts of hyaluronidase in HTK or UW solution substantially improve the recovery of preserved hearts.- Synergistic effects of nafamostat mesilate rinse and Kupffer cell blockade for rat liver preservation.- Tissue hydration in kidneys during preservation: a relaxometric analysis of time-dependent differences between cortex and medulla.- Organ Procurement.- Changes in renal hemodynamics and physiology after normothermic ischemia in animals supplemented with eicosapentaenoic acid.- Donor organ procurement in the North Italy Transplant program (NITp) in 1994: the beginning of a promising trend?.- Regionalization of donor organ procurement: first experiences in southern Bavaria and results of a regional donor hospital survey.- Marginal donors for patients on regular waiting lists for liver transplantation.- Injury to hepatocytes and non-parenchymal cells during the preservation of human livers with UW or HTK solution: a determination of hepatocellular enzymes in the effluent perfusate for preoperative evaluation of the transplant quality.- Pharmacokinetics of rinse solutions at 4 ° Celsius.- Assessment of oxygen radicals during kidney transplantation effect of radical scavenger.- Tissue.- Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease.- Comparative analysis of immunological reconstitution induced by vascularized bone marrow versus bone marrow cell transplantation.